Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 300 of 715 entries
View as:

Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00419796 Org: User:
Start: 11/30/06 End: 09/30/07 Due: 09/30/08

Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.

Phase: N/A Priority: Normal
NCT ID: NCT00242528 Org: User:
Start: 04/30/04 End: - Due: -

A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00170976 Org: User:
Start: 04/30/04 End: 06/30/05 Due: 06/30/06

A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients

Phase: N/A Priority: Normal
NCT ID: NCT00171613 Org: User:
Start: 02/28/05 End: - Due: -

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone

Phase: N/A Priority: Normal
NCT ID: NCT00171002 Org: User:
Start: 11/30/04 End: 06/30/05 Due: 06/30/06

Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14

Phase: N/A Priority: Normal
NCT ID: NCT00254878 Org: User:
Start: 10/31/05 End: 02/28/06 Due: 02/28/07

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants

Phase: N/A Priority: Normal
NCT ID: NCT01437267 Org: User:
Start: 10/31/11 End: 08/31/12 Due: 08/31/13

Drug Interaction of SMC021 With Concomitant Antacid (Calcium Carbonate/Magnesium Hydroxide).

Phase: N/A Priority: Normal
NCT ID: NCT00421590 Org: User:
Start: 10/31/06 End: - Due: -

Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00134953 Org: User:
Start: 01/31/03 End: 05/31/04 Due: 05/31/05

The Effect of Fluvastatin XL® Treatment in Patients With Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00664742 Org: User:
Start: 09/30/06 End: 10/31/07 Due: 10/31/08

Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above

Phase: N/A Priority: Normal
NCT ID: NCT01867021 Org: User:
Start: 05/31/13 End: 12/31/13 Due: 12/31/14

Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients With GI Intolerance

Phase: N/A Priority: Normal
NCT ID: NCT00150020 Org: User:
Start: 10/31/04 End: - Due: -

Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone

Phase: N/A Priority: Normal
NCT ID: NCT00778921 Org: User:
Start: 10/31/08 End: 06/30/09 Due: 06/30/10

Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00546143 Org: User:
Start: 07/31/07 End: - Due: -

Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00426478 Org: User:
Start: 11/30/06 End: 09/30/07 Due: 09/30/08

Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00171795 Org: User:
Start: 11/30/02 End: 05/31/05 Due: 05/31/06

A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00487058 Org: User:
Start: 05/31/07 End: - Due: -

A Study to Evaluate the Effects of Vildagliptin on the Insulin Response to Glucose in Subjects With Pre-diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00312130 Org: User:
Start: 04/30/05 End: 11/30/06 Due: 11/30/07

Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00391976 Org: User:
Start: 11/30/03 End: 01/31/08 Due: 01/31/09

Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00002394 Org: User:
Start: - End: - Due: -

Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00333047 Org: User:
Start: 07/31/02 End: - Due: -

Efficacy and Safety of Lumiracoxib in Patients With Knee Osteoarthritis (OA).

Phase: N/A Priority: Normal
NCT ID: NCT00366938 Org: User:
Start: 09/30/03 End: - Due: -

Study of Omalizumab in Moderate to Severe Bronchial Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00232050 Org: User:
Start: 10/31/02 End: 05/31/05 Due: 05/31/06

Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.

Phase: N/A Priority: Normal
NCT ID: NCT00399659 Org: User:
Start: 11/30/06 End: 04/30/07 Due: 04/30/08

Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients

Phase: N/A Priority: Normal
NCT ID: NCT00572650 Org: User:
Start: 10/31/07 End: 11/30/07 Due: 11/30/08